Magenta Therapeutics
-$0.24 (-16.44%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGTA and other ETFs, options, and stocks.
About MGTA
Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers patient preparation, stem cell collection, cell dose, and safe immune regeneration programs.
CEO
Jason Gardner
Employees
75
Headquarters
Cambridge, Massachusetts
Founded
2015
MGTA Key Statistics
Market cap
71.74M
Price-Earnings ratio
—
Dividend yield
—
Average volume
498.59K
High today
$1.49
Low today
$1.19
Open price
$1.49
Volume
471.90K
52 Week high
$12.98
52 Week low
$0.9231
Analyst ratings
86%
of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
MGTA Earnings
-$0.41
-$0.27
-$0.14
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.31 per share
Actual
-$0.39 per share